Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

• Status: Completed
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to assess local nasal adverse effects, as well as systemic effects, of PATANASE nasal spray when compared with Patanase Vehicle, pH 3.7 and Patanase Vehicle, pH 7.0 in patients with perennial allergic rhinitis (PAR).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Olopatadine Hydrochloride

Criteria

Inclusion Criteria:

1. Sign informed consent;

2. Normal nasal exam;

3. History of perennial allergic rhinitis;

4. Allergy to perennial allergen documented by allergy testing;

5. Age 12 years and older;

6. Must follow instructions;

7. Must make required study visits;

8. Negative pregnancy test and adequate birth control methods for females of childbearing potential;

9. Refrain from certain allergy medications during the study;

10. Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

1. Nasal disorders;

2. Use of substances that affect the nasal septum;

3. Exposure to industrial metal plating solutions;

4. Uncontrolled, severe, or unstable diseases;

5. Hypersensitivity to the study drug or nasal spray components;

6. Relative of site staff with access to the protocol;

7. Participation in another investigational study within 30 days or at the same time as this study;

8. Medical Monitor decision;

9. Other protocol-defined exclusion criteria may apply.